As of 2024, Geoffrey holds about 184,914 shares of Medtronic, alongside numerous stock options and performance share units. His share count has seen growth since his initial grant as a new president, reflecting a stable confidence in Medtronic’s market value....

As of 2024, Geoffrey holds about 184,914 shares of Medtronic, alongside numerous stock options and performance share units. His share count has seen growth since his initial grant as a new president, reflecting a stable confidence in Medtronic’s market value. This includes a noticeable jump in shares when he received a large equity grant during his transition to CEO. His wealth in stock holds significant value but is structured around performance metrics. It’s a strategic position, with his personal finances intertwined with the company’s success, demonstrating the alignment of leadership interests with shareholder value.